This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Adient (ADNT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gentex (GNTX) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of -2.63% and 0.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 10th
by Zacks Equity Research
BWAY, BWAY and AXL have been added to the Zacks Rank #5 (Strong Sell) List on January 10, 2023.
Strength Seen in Adient (ADNT): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
Adient (ADNT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Adient (ADNT) Q4 Earnings & Sales Top Estimates, Increase Y/Y
by Zacks Equity Research
Adient (ADNT) delivers an earnings beat in fourth-quarter fiscal 2022. Its top and bottom lines see year-over-year growth. All the segments report robust growth.
New Strong Sell Stocks for November 7th
by Zacks Equity Research
HOUS, ADNT and ASIX have been added to the Zacks Rank #5 (Strong Sell) List on November 7, 2022.
Adient (ADNT) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 3.92% and 2.83%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Luminar Technologies, Inc. (LAZR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Luminar Technologies, Inc. (LAZR) delivered earnings and revenue surprises of 14.29% and 39.73%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Adient's (ADNT) Deal With EnerTech to Boost Mobility Solutions
by Zacks Equity Research
Adient (ADNT) inks a partnership with the venture capital firm, EnerTech Capital, to enhance its EV expertise and bring in advanced high-tech companies to its network.
Are Options Traders Betting on a Big Move in Adient (ADNT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
Adient (ADNT) Beats on Q3 Earnings & Sales, Revises FY22 View
by Zacks Equity Research
Adient (ADNT) reports a profit in the fiscal third quarter against a loss a year ago. Its top line also sees robust growth. The company modifies its guidance for FY2022.
Adient (ADNT) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 500% and 3.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Adient (ADNT) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Beware of These 2 Auto Equipment Suppliers Amid Industry Woes
by Rimmi Singhi
With the automotive equipment industry struggling with supply chain disruptions and cost woes, we advise you to stay away from stocks like Autoliv (ALV) and Adient (ADNT) to prevent losses.
Adient (ADNT) Q2 Earnings Miss, Sales Beat, '22 View Trimmed
by Zacks Equity Research
Adient (ADNT) now envisions fiscal 2022 revenues of $14.2 billion, down from the prior guidance of $14.8 billion.
Adient (ADNT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -750% and 2.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Adient (ADNT) Q2 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Allison Transmission (ALSN) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Allison Transmission (ALSN) delivered earnings and revenue surprises of 12.07% and 5.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 12th
by Zacks Equity Research
ADNT, FRGI, and COWN have been added to the Zacks Rank #5 (Strong Sell) List on April 12, 2022.
BorgWarner (BWA) Beats on Q4 Earnings, Announces Buyout Deal
by Zacks Equity Research
BorgWarner (BWA) beats Q4 earnings and revenue estimates. Meanwhile, it inks a deal to buy Santroll's light vehicle eMotor business to strengthen its position in electric propulsion systems.
The Zacks Analyst Blog Highlights: Ford, General Motors, Cummins, Adient and Meritor
by Zacks Equity Research
Ford, General Motors, Cummins, Adient and Meritor are included in this analyst blog.
Auto Roundup: Quarterly Earnings in Focus; GM Beats, F Misses & Other Updates
by Rimmi Singhi
While General Motors' (GM) Q4 EPS beat estimates, it dips 30% y/y. Its close peer Ford's (F) Q4 earnings miss mark and decline 23.5% on a year-over-year basis.
Adient (ADNT) Incurs Q1 Loss, Surpasses Sales Estimates
by Zacks Equity Research
Adient (ADNT) incurs a loss in fiscal Q1 due to downsized EBITDA across segments brought about by the global market headwinds.
Adient (ADNT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -575% and 2.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Wabash National (WNC) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Wabash (WNC) delivered earnings and revenue surprises of -41.67% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?